Title: Kenji Uchimura - Innovator in Colorectal Cancer Examination
Introduction
Kenji Uchimura is an inventor based in San Francisco, CA (US). He has made significant contributions to the field of medical diagnostics, particularly in the examination of colorectal cancer and colorectal adenoma. Although he currently holds no granted patents, his work is noteworthy for its potential impact on cancer detection.
Latest Patent Applications
Kenji Uchimura's latest patent application is titled "Method for Examining Colorectal Cancer and Colorectal Adenoma." This invention provides a method for examining colorectal cancer and colorectal adenoma, enabling the detection of colorectal cancer patients and those at high risk with a high probability. The method is useful for diagnosing colorectal cancer and adenoma, and it includes examination reagents. The application highlights significant differences in the distribution of GlcNAc-6-sulfotransferase isozymes among non-cancer colorectal tissues, colorectal cancer tissues, and colorectal adenoma tissues. Furthermore, colorectal cancers and adenomas can be detected specifically by assaying a defined range of GlcNAc-6-sulfated sugar residues in tissues from patients or fecal samples. The MECA-79 antibody, which reacts with GlcNAc-6-sulfated sugar residues produced specifically by the enzyme present in colorectal cancer and adenoma tissues, could be utilized for the examination of these conditions.
Conclusion
Kenji Uchimura's innovative approach to colorectal cancer examination demonstrates his commitment to advancing medical diagnostics. His work has the potential to significantly improve early detection and diagnosis of colorectal cancer and adenoma, ultimately benefiting patient outcomes.